ENROPRO 100 Trademark

Trademark Overview

On Friday, July 12, 2024, a trademark application was filed for ENROPRO 100 with the United States Patent and Trademark Office. The USPTO has given the ENROPRO 100 trademark a serial number of 98645593. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, March 4, 2026. This trademark is owned by Cronus Pharma LLC. The ENROPRO 100 trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical formulation of an antibiotic for bacterial infections
enropro 100

General Information

Serial Number98645593
Word MarkENROPRO 100
Filing DateFriday, July 12, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, March 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements

NOT AVAILABLE"100"
Pseudo MarkENROPRO ONE HUNDRED; ENROPRO ONE ZERO ZERO
Goods and ServicesVeterinary pharmaceutical formulation of an antibiotic for bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCronus Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816
US
Party NameCronus Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEast Brunswick, NJ 08816
US

Trademark Events

Event DateEvent Description
Friday, July 12, 2024NEW APPLICATION ENTERED
Monday, February 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 4, 2025ASSIGNED TO EXAMINER
Wednesday, February 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, February 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 6, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, March 6, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, March 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 22, 2025SOU TEAS EXTENSION RECEIVED
Friday, August 22, 2025SOU EXTENSION 1 FILED
Friday, August 22, 2025SOU EXTENSION 1 GRANTED
Saturday, August 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, March 4, 2026SOU EXTENSION 2 FILED
Wednesday, March 4, 2026SOU EXTENSION 2 GRANTED
Thursday, March 5, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

enropro bacterial infections antibiotic formulation pharmaceutical veterinary